Task Force 4: Inpatient Management of Patients with MCSD - The ...

39. Khalid I, Doshi P, DiGiovine B. Early enteral nutrition and outcomes of critically ill patients
treated with vasopressors and mechanical ventilation. Am J Crit Care. 2010;19(3):261-268.
40. Aslam S, Hernandez M, Thornby J, Zeluff B, Darouiche RO. Risk factors and outcomes of fungal
ventricular-assist device infections. Clin Infect Dis. 2010;50(5):664-671.
41. Bond E, Bolton B, Nelson K. Nursing education and implications for left ventricular assist
device destination therapy. Prog Cardiovasc Nurs. 2004;19(3):95-101.
42. Stahl MA, Richards NM. Ventricular assist devices: developing and maintaining a training and
competency program. J Cardiovasc Nurs. 2002;16(3):34-43.
43. Millhaem TB, Timm K. Identifying the educational needs of nursing staff: the role of the clinical
nurse specialist in perinatal nursing. J Nurses Staff Dev. 2007;23(6):277-282.
44. Savage L, Murphey J, Joyce K. Developing and maintaining competency with circulatory assist
devices: how to meet the challenge. Prog Transplant. 2010;20(2):125-128.
45. Andrus S, Dubois J, Jansen C, Kuttner V, Lansberry N, Lukowski L. Teaching documentation
tool: building a successful discharge. Crit Care Nurse. 2003;23(2):39-48.
46. Holmes EC. Outpatient management of long-term assist devices. Cardiol Clin. 2003;21(1):93-
99.
47. Murray MA, Osaki S, Edwards NM et al. Multidisciplinary approach decreases length of stay
and reduces cost for ventricular assist device therapy. Interact Cardiovasc Thorac Surg.
2009;8(1):84-88.
48. Stahovich M, Chillcott S, Dembitsky WP. The next treatment option: using ventricular assist
devices for heart failure. Crit Care Nurs Q. 2007;30(4):337-346.
49. Moroney DA, Powers K. Outpatient use of left ventricular assist devices: nursing, technical,
and educational considerations. Am J Crit Care. 1997;6(5):355-362.
50. Bond E, Bolton B, Nelson K. Nursing education and implications for left ventricular assist
device destination therapy. Prog Cardiovasc Nurs. 2004;19(3):95-101.
51. Eshelman AK, Mason S, Nemeh H, Williams C. LVAD destination therapy: applying what we
know about psychiatric evaluation and management from cardiac failure and transplant. Heart
Fail Rev. 2009;14(1):21-28.
52. Slaughter MS, Sobieski MA, Martin M, Dia M, Silver MA. Home discharge experience with the
Thoratec TLC-II portable driver. ASAIO J. 2007;53(2):132-135.
53. Dew MA, Kormos RL, Winowich S et al. Quality of life outcomes in left ventricular assist system
inpatients and outpatients. ASAIO J. 1999;45(3):218-225.
54. Grady KL, Meyer P, Mattea A et al. Improvement in quality of life outcomes 2 weeks after left
ventricular assist device implantation. J Heart Lung Transplant. 2001;20(6):657-669.
55. Grady KL, Meyer P, Mattea A et al. Predictors of quality of life at 1 month after implantation of
a left ventricular assist device. Am J Crit Care. 2002;11(4):345-352.
56. National Association of Social Workers. Standards for Social Work Practice in Health Care
Settings. http://www.naswdc.org/practice/standards/naswhealthcarestandards.pdf . 2012.
Ref Type: Online Source
57. Adams J, Kuchibhatla M, Christopher EJ et al. Association of Depression and Survival in
Patients with Chronic Heart Failure over 12 Years. Psychosomatics. 2012.
58. Jiang W, O'Connor C, Silva SG et al. Safety and efficacy of sertraline for depression in patients
with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline
for major depression with congestive heart failure. Am Heart J. 2008;156(3):437-444.
59. O'Connor CM, Jiang W, Kuchibhatla M et al. Safety and efficacy of sertraline for depression in
patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and
Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol. 2010;56(9):692-699.
44